Clinical Trials on Antiplatelet Therapy

Total 2579 results

Beijing Anzhen Hospital

Unknown

The Influence of Gene Polymorphism on Clinical Outcomes in Patients Undergoing PCI

Antiplatelet Therapy | CYP2C19 Polymorphism

China
Rabin Medical Center

Unknown

Is There a Transient Rebound Effect of Platelet Reactivity Following Cessation of Dual Antiplatelet Therapy With Ticagrelor - a Single Center Prospective Observational Trial

Platelet Reactivity | Dual Antiplatelet Therapy

Israel
Chinese Academy of Medical Sciences, Fuwai Hospital

Completed

A Single-center, Prospective,Randomized Study of Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting (ATCCC)

Antiplatelet Therapy of Coronary Artery Bypass

China
Ruijin Hospital

Completed

DACAB Trial: Follow-up Extension (DACAB-FE)

Coronary Artery Bypass Grafting | Antiplatelet Therapy

China
Taipei City Hospital

Completed

Platelet Reactivity (High On-Treatment Platelet Reactivity) as Guidance for APT (Antiplatelet Therapy) Adjustment After PCI (Percutaneous Coronary Intervention)

PRU(Platelet Reactivity Unit) | APT(Antiplatelet Therapy) | HOTPR(High on Treat Platelet Reactivity)

Taiwan
Azienda Ospedaliero Universitaria Maggiore della...
Abbott Medical Devices

Recruiting

Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy After Percutaneous Left Atrial Appendage Closure: a Multicenter, Randomized Study (ARMYDA-AMULET)

Left Atrial Appendage Occlusion | Antiplatelet Therapy

Italy
Icahn School of Medicine at Mount Sinai
Daiichi Sankyo, Inc.; Accumetrics, Inc.

Completed

Patients Undergoing Percutaneous Coronary Intervention (PCI) Through Optimal Platelet Inhibition (TRIAGE)

Aspirin | Percutaneous Coronary Intervention | Dual Antiplatelet Therapy | Clopidogrel

United States
Ottawa Heart Institute Research Corporation

Terminated

A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)

Percutaneous Coronary Intervention | Ticagrelor | Antiplatelet Therapy | Stable Coronary Syndrome

Canada
OCEAN-SHD Study Group

Recruiting

Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial

Aortic Stenosis | Aspirin | TAVI(Transcatheter Aortic Valve Implantation) | DAPT(Dual Antiplatelet Therapy) | SAPT(Single Antiplatelet Therapy)

Japan
Shenyang Northern Hospital

Not yet recruiting

OCT or Angiography Guided De-escalation of DAPT

ST Elevation Myocardial Infarction | Dual Antiplatelet Therapy | Optical Coherence Tomography | Antiplatelet De-escalation | Neointimal Coverage

China
Careggi Hospital

Completed

Pocket Haematoma Prevention in Patients Who Required Implantation/Replacement of a Pacemaker or Implantable Cardiac Defibrillator. The PHP Study. (PHP)

Pacemaker Implantation | Pocket Hematoma and Bleeding | Antiplatelet Therapy or Oral Anticoagulants

Italy
Seoul National University Bundang Hospital

Completed

Does Pantoprazole Reduce the Anti-platelet Effect of Clopidogrel?

Antiplatelet Effect

Korea, Republic of
AstraZeneca

Completed

Study to Investigate Safety and Tolerability of a Single Dose of AZD6482

Antiplatelet Effect
Lee's Pharmaceutical Limited

Suspended

Antiplatelet Thrombolysin (Anfibatide) Phase 1 Clinical Trial in Healthy Volunteers

Antiplatelet Drug

China
Genoss Co., Ltd.

Recruiting

Evaluating Efficacy and Safety of Short Duration of DAPT After Genoss DES Stent Implantation in Patients (DAPTShort)

Acute Coronary Syndrome | Percutaneous Coronary Intervention | Dual Antiplatelet Therapy

Korea, Republic of
Shenyang Northern Hospital

Unknown

Platelet Reactivity And Clinical ThrombotIC Events Study (PRACTICE)

Acute Coronary Syndrome | Platelet Reactivity | Antiplatelet Therapy

China
Brigham and Women's Hospital

Completed

Replication of the PLATO Antiplatelet Trial in Healthcare Claims Data

Antiplatelet

United States
Brigham and Women's Hospital

Completed

Replication of the TRITON-TIMI Antiplatelet Trial in Healthcare Claims Data

Antiplatelet

United States
Chiang Mai University

Unknown

Continue vs. Stop P2Y12 Inhibitor on Bleeding in Patient Receiving DAPT Undergoing Dental Procedure.

Antiplatelet Agents | Dental Diseases | Antiplatelet Drugs
Hôpital de la Timone

Unknown

Timing of Optimal Platelet Inhibition After Acute Coronary Syndrome (TOPIC)

Acute Coronary Syndrome | Antiplatelet Therapy | Coronary Stenting

France
Jung-min Ahn
CardioVascular Research Foundation, Korea

Recruiting

Perioperative Antiplatelet Therapy in Patients With Drug-eluting Stent Undergoing Noncardiac Surgery (ASSURE-DES)

Antiplatelet Drugs

Korea, Republic of, India, Turkey
Bristol-Myers Squibb
Sanofi

Completed

A Study to Evaluate the Discontinuation Effect of Clopidogrel After Drug Eluting Stent Implantation in Non-diabetic Patients (DECADES)

Antiplatelet Aggregation

France, Germany, Netherlands, United Kingdom
Chang Gung Memorial Hospital

Recruiting

Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease (SATBRAD)

Dual Antiplatelet Therapy | Acute Stroke | Statin

Taiwan
Careggi Hospital

Completed

REsponsiveness to CLOpidogrel and Stent-related Events in Acute Coronary Syndromes (RECLOSE 2 - ACS) (RECLOSE2-ACS)

Stent Thrombosis | Platelet Function | Antiplatelet Therapy | Acute Cardiac Syndrome

Italy
Genoss Co., Ltd.

Recruiting

Evaluating Efficacy and Safety of 1-year of DAPT After Genoss DES Sirolimus-eluting Stent Implantation in Patients (DAPTLONG)

Coronary Artery Disease | Percutaneous Coronary Intervention | Dual Antiplatelet Therapy

Korea, Republic of
Research Maatschap Cardiologen Rotterdam Zuid
Abbott Medical Devices

Recruiting

Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients

ST Elevated Myocardial Infarction | Dual Antiplatelet Therapy

Netherlands, Germany, Italy
Shanghai MicroPort Medical (Group) Co., Ltd.

Recruiting

Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease

Coronary Disease | Percutaneous Coronary Intervention | Dual Antiplatelet Therapy | Drug Eluting Stent

China
Ruijin Hospital

Completed

Different Antiplatelet Therapy Strategy After Coronary Artery Bypass Graft Surgery (DACAB)

Coronary Artery Bypass | Antiplatelet Agents

China
Beijing Anzhen Hospital

Unknown

LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention (LOTIC)

Coronary Artery Disease | Percutaneous Coronary Intervention | Antiplatelet Therapy

China
China National Center for Cardiovascular Diseases

Not yet recruiting

24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels (DAPT-Lp(a))

Coronary Artery Disease | Dual Antiplatelet Therapy | Elevated Lipoprotein(a) Level | Drug-Eluting Stent

China
Hotel Dieu de France Hospital

Unknown

Ticagrelor and Endothelial Function

Antiplatelet Agents; Endothelial Function; Pleotropic Effects

Lebanon
Seoul National University Hospital

Unknown

Ethnic Differences and the Ischemia/Bleeding Risk of DAPT Duration

Coronary Artery Disease | Percutaneous Coronary Intervention | Dual Antiplatelet Therapy

Korea, Republic of
Second Affiliated Hospital, School of Medicine,...
Ningbo Medical Center Lihuili Hospital; Shenzhen Second People's Hospital; Shaoxing... and other collaborators

Recruiting

Early Antiplatelet Therapy After Hemorrhagic Infarction in Acute Ischemic Stroke Treated With Intravenous Thrombolysis (HITs)

Antiplatelet Therapy | Hemorrhagic Infarction

China
Azienda Ospedaliera Universitaria Policlinico "G...
Gianluca Di Bella; Antonio Micari; Giampiero Vizzari; Giorgio Quadri; Greca Zanda; Ferdinando...

Recruiting

De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS (DESC-HBR)

Coronary Artery Disease | Acute Coronary Syndrome | Dual Antiplatelet Therapy

Italy
AstraZeneca

Completed

Bleeding Time Study With AZD6482, Clopidogrel and ASA

Antiplatelet Effect

Sweden
University of Aarhus
AP Moeller Foundation

Completed

Platelet Inhibition in the Acute Phase of STEMI

Acute Myocardial Infarction | ST-segment Elevation Myocardial Infarction (STEMI) | Antiplatelet Therapy

Denmark
Guangdong Provincial People's Hospital
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Zhongshan People's... and other collaborators

Unknown

Long-term MOno-Antiplatelet Drug Strategy After PerCutanEous CoronAry InterveNtion (RESCIND-OCEAN)

Antiplatelet Drug-related Gastrointestinal Injury

China
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor

Coronary Artery Disease | Platelet Aggregation | Kidney Dysfunction | Adenosine | Antiplatelet Therapy

Brazil
China National Center for Cardiovascular Diseases

Recruiting

Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting (TOP-CABG)

Myocardial Infarction | Myocardial Ischemia | Coronary Artery Disease | Bleeding | Angina Pectoris | Dual Antiplatelet Therapy | Coronary Artery Bypass Grafting

China
University of Seville

Completed

Efficacy of Vestibular Physiotherapy Against Multi-component Exercise in Functional Improvement in the Elderly

Gait | Physical Therapy | Sports Physical Therapy | Exercise Therapy

Spain
Biotronik SE & Co. KG

Completed

BIO|MASTER.Edora Family Study

Cardiac Resynchronization Therapy | Pacemaker Therapy

Germany, Austria, Spain, Switzerland
Rennes University Hospital
Roche Diagnostics

Completed

Medico-economic Interest of the Protein S100b in Mild Head Trauma Under Anti-thrombotics (ISTCAT)

Anticoagulant | Mild Head Injury | Antiplatelet

France
David Antoniucci
A.R. CARD Onlus Foundation

Terminated

BLeeding Events and Maintenance DoSe of PraSugrel (BLESS)

Acute Coronary Syndrome | Adverse Reaction to Antiplatelet Agent

Italy
David Antoniucci
AstraZeneca; A.R. CARD Onlus Foundation

Completed

Mojito Study (Mashed Or Just Integral Pill of TicagrelOr ? )

Acute Coronary Syndrome | Adverse Reaction to Antiplatelet Agent

Italy, Greece
University of Sao Paulo

Unknown

A Multi-component Intervention in Frail Community-dwelling Older People (MIF)

Frail Elderly | Exercise Therapy | Physical Therapy Techniques
Universidad de Almeria
Andaluz Health Service

Completed

Effectiveness of Cervicothoracic Manipulative Treatment in Unilateral Shoulder Impingement Syndrome: A Randomized Controlled Trial.

Shoulder Pain | Manual Theapy | Exercises Therapy

Spain
Palo Alto Veterans Institute for Research

Completed

Written Versus Verbal Brief Cognitive Behavioral Exposure Therapy

Written Exposure Therapy | Imaginal Exposure Therapy

United States
University of Nebraska

Recruiting

Robot Rehab: AAI With Robot During Inpatient Pediatric Rehab

Pediatric ALL | Child, Hospitalized | Occupational Therapy | Physical Therapy Modalities | Animal Assisted Therapy

United States
First Affiliated Hospital of Zhejiang University

Recruiting

Effect of Anticoagulant Drug Intervention on Postoperative MALE and MACE in Patients With PAD

Peripheral Arterial Disease | Anticoagulant Drugs | Antiplatelet Drug

China
Guangzhou Concord Cancer Center
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Varian, a Siemens...

Completed

Study on the Safety and Effectiveness of Varian ProBeam Proton Therapy Equipment in the Treatment of Solid Tumors

Solid Tumor | Proton Therapy | Radiation Therapy

China

Clinical Trials on Antiplatelet Therapy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations